Abstract:Jing Liu, 1, &ast Tingting Hu, 2, 3, &ast Yulan Guan, 2, 4 Jinguo Zhai 2 1 Department of Gynecology, The Fifth Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, 510700, People's Republic of China; 2 School of Nursing, Southern Medical University, Guangzhou, Guangdong, 510515, People's Republic of China; 3 Department of Gynecology, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou, Guangdong, 510180, People's Republic of China; 4 Department of Gynecology, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou, Guangdong, 510105, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yulan Guan, Department of Gynecology, Guangdong Provincial Hospital of Chinese Medicine, No. 261 Datong Road, Yuexiu District, Guangzhou, 510105, People's Republic of China, Tel +8615989117143, Email Jinguo Zhai, Nursing School, Southern Medical University, No. 1023-1063 Sha Tai Nan Road, Baiyun District, Guangzhou, 510515, People's Republic of China, Tel +8618620287620, Email Purpose: To explore the risk and protective factors for developing ovarian cancer and construct a risk prediction model. Methods: Information related to patients diagnosed with ovarian cancer on the electronic medical record data platform of three tertiary hospitals in Guangdong Province from May 2018 to September 2023 was collected as the case group. Patients with non-ovarian cancer who attended the clinic during the same period were included in the control group. Logistic regression analysis was used to screen the independent variables and explore the factors associated with the development of ovarian cancer. An ovarian cancer risk prediction model was constructed using a decision tree C4.5 algorithm. The ROC and calibration curves were plotted, and the model was validated. Results: Logistic regression analysis identified independent risk and protective factors for ovarian cancer. The sample size was divided into training and test sets in a ratio of 7:3 for model construction and validation. The AUC of the training and test sets of the decision tree model were 0.961 (95% CI:0.944– 0.978) and 0.902 (95% CI:0.840– 0.964), respectively, and the optimal cut-off values and their coordinates were 0.532 (0.091, 0.957), and 0.474 (0.159, 0.842) respectively. The accuracies of the training and test sets were 93.3% and 84.2%, respectively, and their sensitivities were 95.7% and 84.2%, respectively. Conclusion: The constructed ovarian cancer risk prediction model has good predictive ability, which is conducive to improving the efficiency of early warning of ovarian cancer in high-risk groups. Keywords: ovarian cancer, incidence factors, decision tree model, risk prediction Ovarian cancer (OC) is a common malignant tumor of the female reproductive system, ranking 3rd among gynecological malignancies. 1 90% of ovarian cancers are of an epithelial cell type and comprise multiple histologic types, with various specific molecular changes, clinical behaviors, and treatment outcomes. The remaining 10% are non-epithelial ovarian cancers, which include mainly germ cell tumors, sex cord-stromal tumors, and some sporadic tumors such as small cell carcinomas. Germ cell tumors are the most common ovarian neoplasms in women up to 30 years of age, and most of the patients are diagnosed with early-stage disease (60–70%). 2 There are approximately 200,000 new cases of ovarian cancer globally every year, with a mortality rate as high as 125,000 cases/year. Interestingly, the prevalence of asymptomatic ovarian masses has risen alongside the widespread use of prenatal ultrasonography. Approximately 5% of ovarian tumors complicating pregnancies, are malignant, contributing to the global increase in new cases of ovarian cancer. Currently, surgical intervention is indicated for an ovarian mass > 6 cm in diameter or when symptomatic. 3 Incidence trends differ between countries and regions; 4 the incidence rate of ovarian cancer in developed countries is decreasing by 2.8% annually on average. 5 In China, however, the incidence of ovarian cancer is increasing, and the number of new cases and deaths from ovarian cancer is expected to more than triple between 2019 and 2049. 6 Survey data from Shanghai, China, show that the incidence of ovarian cancer is increasing at a rate of 1.8% annually, and the annual mortality rate is expected to increase by 0.6%. 7 The onset of ovarian cancer is insidious, with atypical initial symptoms, making detection by patients or diagnosis by do -Abstract Truncated-

Causal relationship between amino acids and ovarian cancer in the European population: A bidirectional Mendelian randomization study and meta-analysis

European Ancestry And Ovarian Cancer: Testing For Their Association Using Case Control Data

Abstract 1352: Epithelial-mesenchymal Transition (EMT) Gene Variants Influence Epithelial Ovarian Cancer Risk in Women of European, African and Asian Ancestry.

Appraising the Role of Circulating Concentrations of Micro-Nutrients in Epithelial Ovarian Cancer Risk: A Mendelian Randomization Analysis

Gut microbiota and risk of ovarian diseases: a two-sample Mendelian randomization study

Large-scale analysis to identify risk factors for ovarian cancer

Association between gut microbiota, plasma metabolites, and ovarian cancer: A Mendelian randomization study

Unveiling the causal link between metabolic factors and ovarian cancer risk using Mendelian randomization analysis

Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis

Genetic links between ovarian ageing, cancer risk and de novo mutation rates

Review of Mendelian Randomization Studies on Ovarian Cancer

Association of Vitamin D Levels and Risk of Ovarian Cancer: A Mendelian Randomization Study

Genetically predicted blood metabolites mediate relationships between gut microbiota and ovarian cancer: a Mendelian randomization study

Genetically identification of endometriosis and cancers risk in women through a two-sample Mendelian randomization study

Age at first birth, age at menopause, and risk of ovarian cyst: a two-sample Mendelian randomization study

Investigation on factors associated with ovarian cancer: an umbrella review of systematic review and meta-analyses

The Associations and Causal Relationships of Ovarian Cancer - Construction of a Prediction Model

Risk factors for ovarian cancer by BRCA status: a collaborative case-only analysis

Bidirectional Mendelian randomization study of insulin-related traits and risk of ovarian cancer

Causal association between 637 human metabolites and ovarian cancer: a mendelian randomization study

Endometriosis and epithelial ovarian cancer: a two-sample Mendelian randomization analysis